SCYX CIK: 1178253

SCYNEXIS, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
millions USD
FY21:
12.9
FY22:
4.46
FY23:
125
FY24:
3.75
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−61.2
FY22:
−86.4
FY23:
57.0
FY24:
−37.1
FY25:
−16.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−61.7
FY22:
−85.3
FY23:
74.2
FY24:
−34.3
FY25:
−14.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.0
FY22:
−67.5
FY23:
67.2
FY24:
−21.1
FY25:
−8.61
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.9
FY22:
−62.8
FY23:
67.0
FY24:
−21.3
FY25:
−8.61

All amounts in millions USD Data sources:SEC EDGARTwelve Data